02/05/2026
At CureMatch, we see cancer not just as a diagnosis, but as a deeply personal story—one unique molecular fingerprint at a time.
Every day, we receive messages that stay with us:
A daughter writing on behalf of her father, asking if there’s still a path forward when standard options have run out.
A young mother fighting stage IV, determined to walk her child down the aisle someday.
An oncologist who refuses to accept “there’s nothing more we can do,” reaching out in the quiet hours for one more combination that might change everything.
Behind each of those messages is real courage—and real lives hanging in the balance.
Our system serves as a GPS that helps navigate cancer complexity. It is an “Assistive AI” physicians use to inform their therapy decisions on molecular personalized basis.
Our platform doesn’t promise miracles. What it does is give precision where there was once guesswork: analyzing a patient’s full tumor profile, filtering, scoring, and ranking most molecularly matching therapies (including combinations), incorporating all the latest scientific evidence, FDA labels, drug mechanisms, resistance and sensitivity markers, and clinical trials into its algorithms and generating a concise report.
We’ve seen progression-free survival improve significantly in patients treated with high-match combinations.
We’ve watched physicians gain clarity in minutes instead of days or weeks. And most importantly, we’ve witnessed hope rekindled—not as false optimism, but as actionable, science-backed possibility.
Cancer may feel relentless, but it is not unbeatable.
Every mutation tells a story.
Every story deserves the best chapter possible.
If you’re an oncologist, a researcher, a patient advocate, or someone who’s been touched by cancer—thank you for fighting alongside us.
If you’re facing this disease or supporting someone who is—know that precision medicine is evolving faster than ever, and we’re here to help light the way.
Let’s keep turning data into decisions, despair into determination, and “what if” into “what now.”
Together, we outsmart cancer—one patient at a time. Razelle Kurzrock
